nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2C19—Rosuvastatin—atherosclerosis	0.0635	0.089	CbGbCtD
Tranylcypromine—CYP2C19—Simvastatin—atherosclerosis	0.059	0.0827	CbGbCtD
Tranylcypromine—CYP2C19—Lovastatin—atherosclerosis	0.0578	0.081	CbGbCtD
Tranylcypromine—CYP2D6—Niacin—atherosclerosis	0.0568	0.0796	CbGbCtD
Tranylcypromine—CYP2C9—Rosuvastatin—atherosclerosis	0.0528	0.074	CbGbCtD
Tranylcypromine—CYP2C9—Simvastatin—atherosclerosis	0.0491	0.0688	CbGbCtD
Tranylcypromine—CYP2C9—Pravastatin—atherosclerosis	0.048	0.0673	CbGbCtD
Tranylcypromine—CYP2C9—Lovastatin—atherosclerosis	0.048	0.0673	CbGbCtD
Tranylcypromine—CYP2D6—Simvastatin—atherosclerosis	0.0449	0.0629	CbGbCtD
Tranylcypromine—CYP2D6—Pravastatin—atherosclerosis	0.0439	0.0616	CbGbCtD
Tranylcypromine—CYP2D6—Lovastatin—atherosclerosis	0.0439	0.0616	CbGbCtD
Tranylcypromine—CYP3A4—Rosuvastatin—atherosclerosis	0.0307	0.043	CbGbCtD
Tranylcypromine—CYP3A4—Ezetimibe—atherosclerosis	0.0307	0.043	CbGbCtD
Tranylcypromine—CYP3A4—Simvastatin—atherosclerosis	0.0285	0.04	CbGbCtD
Tranylcypromine—CYP3A4—Pravastatin—atherosclerosis	0.0279	0.0391	CbGbCtD
Tranylcypromine—CYP3A4—Lovastatin—atherosclerosis	0.0279	0.0391	CbGbCtD
Tranylcypromine—Memory loss—Rosuvastatin—atherosclerosis	0.00958	0.0459	CcSEcCtD
Tranylcypromine—Memory loss—Lovastatin—atherosclerosis	0.00812	0.0389	CcSEcCtD
Tranylcypromine—Memory loss—Ezetimibe—atherosclerosis	0.00796	0.0381	CcSEcCtD
Tranylcypromine—Memory loss—Simvastatin—atherosclerosis	0.00759	0.0364	CcSEcCtD
Tranylcypromine—Memory loss—Pravastatin—atherosclerosis	0.00686	0.0329	CcSEcCtD
Tranylcypromine—Blood disorder—Rosuvastatin—atherosclerosis	0.00337	0.0161	CcSEcCtD
Tranylcypromine—Tenderness—Lovastatin—atherosclerosis	0.00273	0.0131	CcSEcCtD
Tranylcypromine—Tenderness—Simvastatin—atherosclerosis	0.00256	0.0122	CcSEcCtD
Tranylcypromine—Numbness—Pravastatin—atherosclerosis	0.00243	0.0117	CcSEcCtD
Tranylcypromine—Sensory loss—Pravastatin—atherosclerosis	0.00233	0.0112	CcSEcCtD
Tranylcypromine—Tenderness—Pravastatin—atherosclerosis	0.00231	0.0111	CcSEcCtD
Tranylcypromine—Amnesia—Rosuvastatin—atherosclerosis	0.00217	0.0104	CcSEcCtD
Tranylcypromine—Amnesia—Lovastatin—atherosclerosis	0.00184	0.00883	CcSEcCtD
Tranylcypromine—Amnesia—Ezetimibe—atherosclerosis	0.00181	0.00866	CcSEcCtD
Tranylcypromine—Amnesia—Simvastatin—atherosclerosis	0.00172	0.00826	CcSEcCtD
Tranylcypromine—Amnesia—Pravastatin—atherosclerosis	0.00156	0.00746	CcSEcCtD
Tranylcypromine—Urinary retention—Niacin—atherosclerosis	0.00141	0.00677	CcSEcCtD
Tranylcypromine—Hepatitis—Rosuvastatin—atherosclerosis	0.00141	0.00677	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00138	0.0066	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00135	0.00647	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00129	0.00617	CcSEcCtD
Tranylcypromine—Hepatitis—Lovastatin—atherosclerosis	0.0012	0.00574	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Niacin—atherosclerosis	0.00118	0.00567	CcSEcCtD
Tranylcypromine—Hepatitis—Ezetimibe—atherosclerosis	0.00117	0.00563	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00117	0.00558	CcSEcCtD
Tranylcypromine—Hepatitis—Simvastatin—atherosclerosis	0.00112	0.00537	CcSEcCtD
Tranylcypromine—Flushing—Lovastatin—atherosclerosis	0.00111	0.00532	CcSEcCtD
Tranylcypromine—Sweating—Niacin—atherosclerosis	0.0011	0.00526	CcSEcCtD
Tranylcypromine—Flushing—Ezetimibe—atherosclerosis	0.00109	0.00522	CcSEcCtD
Tranylcypromine—Chills—Lovastatin—atherosclerosis	0.00107	0.00515	CcSEcCtD
Tranylcypromine—Alopecia—Lovastatin—atherosclerosis	0.00106	0.00507	CcSEcCtD
Tranylcypromine—Flushing—Simvastatin—atherosclerosis	0.00104	0.00498	CcSEcCtD
Tranylcypromine—Alopecia—Ezetimibe—atherosclerosis	0.00104	0.00497	CcSEcCtD
Tranylcypromine—Haemoglobin—Niacin—atherosclerosis	0.00103	0.00495	CcSEcCtD
Tranylcypromine—Haemorrhage—Niacin—atherosclerosis	0.00103	0.00493	CcSEcCtD
Tranylcypromine—Hepatitis—Niacin—atherosclerosis	0.00103	0.00493	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Niacin—atherosclerosis	0.00102	0.0049	CcSEcCtD
Tranylcypromine—Hepatitis—Pravastatin—atherosclerosis	0.00101	0.00485	CcSEcCtD
Tranylcypromine—Confusional state—Rosuvastatin—atherosclerosis	0.00101	0.00485	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00101	0.00483	CcSEcCtD
Tranylcypromine—Chills—Simvastatin—atherosclerosis	0.00101	0.00481	CcSEcCtD
Tranylcypromine—Muscle spasms—Lovastatin—atherosclerosis	0.001	0.0048	CcSEcCtD
Tranylcypromine—Alopecia—Simvastatin—atherosclerosis	0.00099	0.00474	CcSEcCtD
Tranylcypromine—Muscle spasms—Ezetimibe—atherosclerosis	0.000983	0.00471	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000983	0.00471	CcSEcCtD
Tranylcypromine—Vision blurred—Lovastatin—atherosclerosis	0.000983	0.00471	CcSEcCtD
Tranylcypromine—Tremor—Lovastatin—atherosclerosis	0.000977	0.00468	CcSEcCtD
Tranylcypromine—Tinnitus—Niacin—atherosclerosis	0.000959	0.00459	CcSEcCtD
Tranylcypromine—Flushing—Niacin—atherosclerosis	0.000955	0.00457	CcSEcCtD
Tranylcypromine—Anaemia—Ezetimibe—atherosclerosis	0.000945	0.00453	CcSEcCtD
Tranylcypromine—Tinnitus—Pravastatin—atherosclerosis	0.000944	0.00452	CcSEcCtD
Tranylcypromine—Flushing—Pravastatin—atherosclerosis	0.00094	0.0045	CcSEcCtD
Tranylcypromine—Muscle spasms—Simvastatin—atherosclerosis	0.000938	0.00449	CcSEcCtD
Tranylcypromine—Leukopenia—Lovastatin—atherosclerosis	0.000933	0.00447	CcSEcCtD
Tranylcypromine—Chills—Niacin—atherosclerosis	0.000923	0.00442	CcSEcCtD
Tranylcypromine—Vision blurred—Simvastatin—atherosclerosis	0.000919	0.0044	CcSEcCtD
Tranylcypromine—Tremor—Simvastatin—atherosclerosis	0.000914	0.00438	CcSEcCtD
Tranylcypromine—Alopecia—Niacin—atherosclerosis	0.000909	0.00435	CcSEcCtD
Tranylcypromine—Chills—Pravastatin—atherosclerosis	0.000909	0.00435	CcSEcCtD
Tranylcypromine—Insomnia—Rosuvastatin—atherosclerosis	0.000908	0.00435	CcSEcCtD
Tranylcypromine—Palpitations—Ezetimibe—atherosclerosis	0.000904	0.00433	CcSEcCtD
Tranylcypromine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000902	0.00432	CcSEcCtD
Tranylcypromine—Anaemia—Simvastatin—atherosclerosis	0.000902	0.00432	CcSEcCtD
Tranylcypromine—Alopecia—Pravastatin—atherosclerosis	0.000895	0.00429	CcSEcCtD
Tranylcypromine—Anxiety—Lovastatin—atherosclerosis	0.000885	0.00424	CcSEcCtD
Tranylcypromine—Hypertension—Ezetimibe—atherosclerosis	0.000883	0.00423	CcSEcCtD
Tranylcypromine—Leukopenia—Simvastatin—atherosclerosis	0.000873	0.00418	CcSEcCtD
Tranylcypromine—Dry mouth—Lovastatin—atherosclerosis	0.000868	0.00416	CcSEcCtD
Tranylcypromine—Muscle spasms—Niacin—atherosclerosis	0.000861	0.00412	CcSEcCtD
Tranylcypromine—Constipation—Rosuvastatin—atherosclerosis	0.000859	0.00411	CcSEcCtD
Tranylcypromine—Pain—Rosuvastatin—atherosclerosis	0.000859	0.00411	CcSEcCtD
Tranylcypromine—Confusional state—Lovastatin—atherosclerosis	0.000858	0.00411	CcSEcCtD
Tranylcypromine—Dry mouth—Ezetimibe—atherosclerosis	0.000852	0.00408	CcSEcCtD
Tranylcypromine—Muscle spasms—Pravastatin—atherosclerosis	0.000848	0.00406	CcSEcCtD
Tranylcypromine—Vision blurred—Niacin—atherosclerosis	0.000844	0.00404	CcSEcCtD
Tranylcypromine—Confusional state—Ezetimibe—atherosclerosis	0.000842	0.00403	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000833	0.00399	CcSEcCtD
Tranylcypromine—Vision blurred—Pravastatin—atherosclerosis	0.000831	0.00398	CcSEcCtD
Tranylcypromine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000828	0.00396	CcSEcCtD
Tranylcypromine—Anxiety—Simvastatin—atherosclerosis	0.000828	0.00396	CcSEcCtD
Tranylcypromine—Tremor—Pravastatin—atherosclerosis	0.000826	0.00396	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000821	0.00393	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000817	0.00391	CcSEcCtD
Tranylcypromine—Anaemia—Pravastatin—atherosclerosis	0.000815	0.0039	CcSEcCtD
Tranylcypromine—Anorexia—Lovastatin—atherosclerosis	0.000811	0.00388	CcSEcCtD
Tranylcypromine—Syncope—Niacin—atherosclerosis	0.000803	0.00385	CcSEcCtD
Tranylcypromine—Confusional state—Simvastatin—atherosclerosis	0.000803	0.00384	CcSEcCtD
Tranylcypromine—Leukopenia—Niacin—atherosclerosis	0.000802	0.00384	CcSEcCtD
Tranylcypromine—Urticaria—Rosuvastatin—atherosclerosis	0.000798	0.00382	CcSEcCtD
Tranylcypromine—Oedema—Simvastatin—atherosclerosis	0.000796	0.00381	CcSEcCtD
Tranylcypromine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000794	0.0038	CcSEcCtD
Tranylcypromine—Palpitations—Niacin—atherosclerosis	0.000791	0.00379	CcSEcCtD
Tranylcypromine—Leukopenia—Pravastatin—atherosclerosis	0.000789	0.00378	CcSEcCtD
Tranylcypromine—Loss of consciousness—Niacin—atherosclerosis	0.000787	0.00377	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000779	0.00373	CcSEcCtD
Tranylcypromine—Insomnia—Lovastatin—atherosclerosis	0.00077	0.00369	CcSEcCtD
Tranylcypromine—Paraesthesia—Lovastatin—atherosclerosis	0.000764	0.00366	CcSEcCtD
Tranylcypromine—Hypertension—Pravastatin—atherosclerosis	0.000761	0.00365	CcSEcCtD
Tranylcypromine—Anorexia—Simvastatin—atherosclerosis	0.000759	0.00363	CcSEcCtD
Tranylcypromine—Insomnia—Ezetimibe—atherosclerosis	0.000755	0.00362	CcSEcCtD
Tranylcypromine—Paraesthesia—Ezetimibe—atherosclerosis	0.00075	0.00359	CcSEcCtD
Tranylcypromine—Anxiety—Pravastatin—atherosclerosis	0.000748	0.00358	CcSEcCtD
Tranylcypromine—Dry mouth—Niacin—atherosclerosis	0.000746	0.00357	CcSEcCtD
Tranylcypromine—Decreased appetite—Lovastatin—atherosclerosis	0.00074	0.00354	CcSEcCtD
Tranylcypromine—Oedema—Niacin—atherosclerosis	0.000731	0.0035	CcSEcCtD
Tranylcypromine—Pain—Lovastatin—atherosclerosis	0.000728	0.00349	CcSEcCtD
Tranylcypromine—Constipation—Lovastatin—atherosclerosis	0.000728	0.00349	CcSEcCtD
Tranylcypromine—Confusional state—Pravastatin—atherosclerosis	0.000726	0.00348	CcSEcCtD
Tranylcypromine—Decreased appetite—Ezetimibe—atherosclerosis	0.000726	0.00347	CcSEcCtD
Tranylcypromine—Asthenia—Rosuvastatin—atherosclerosis	0.000721	0.00345	CcSEcCtD
Tranylcypromine—Insomnia—Simvastatin—atherosclerosis	0.00072	0.00345	CcSEcCtD
Tranylcypromine—Oedema—Pravastatin—atherosclerosis	0.00072	0.00345	CcSEcCtD
Tranylcypromine—Shock—Niacin—atherosclerosis	0.000719	0.00344	CcSEcCtD
Tranylcypromine—Paraesthesia—Simvastatin—atherosclerosis	0.000715	0.00342	CcSEcCtD
Tranylcypromine—Constipation—Ezetimibe—atherosclerosis	0.000714	0.00342	CcSEcCtD
Tranylcypromine—Pain—Ezetimibe—atherosclerosis	0.000714	0.00342	CcSEcCtD
Tranylcypromine—Tachycardia—Niacin—atherosclerosis	0.000713	0.00342	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Niacin—atherosclerosis	0.000707	0.00338	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000705	0.00337	CcSEcCtD
Tranylcypromine—Feeling abnormal—Lovastatin—atherosclerosis	0.000701	0.00336	CcSEcCtD
Tranylcypromine—Anorexia—Niacin—atherosclerosis	0.000697	0.00334	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000696	0.00333	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000696	0.00333	CcSEcCtD
Tranylcypromine—Decreased appetite—Simvastatin—atherosclerosis	0.000692	0.00331	CcSEcCtD
Tranylcypromine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000688	0.00329	CcSEcCtD
Tranylcypromine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000687	0.00329	CcSEcCtD
Tranylcypromine—Anorexia—Pravastatin—atherosclerosis	0.000686	0.00329	CcSEcCtD
Tranylcypromine—Hypotension—Niacin—atherosclerosis	0.000683	0.00327	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000683	0.00327	CcSEcCtD
Tranylcypromine—Constipation—Simvastatin—atherosclerosis	0.000681	0.00326	CcSEcCtD
Tranylcypromine—Pain—Simvastatin—atherosclerosis	0.000681	0.00326	CcSEcCtD
Tranylcypromine—Urticaria—Lovastatin—atherosclerosis	0.000676	0.00324	CcSEcCtD
Tranylcypromine—Abdominal pain—Lovastatin—atherosclerosis	0.000673	0.00322	CcSEcCtD
Tranylcypromine—Body temperature increased—Lovastatin—atherosclerosis	0.000673	0.00322	CcSEcCtD
Tranylcypromine—Dizziness—Rosuvastatin—atherosclerosis	0.000664	0.00318	CcSEcCtD
Tranylcypromine—Urticaria—Ezetimibe—atherosclerosis	0.000663	0.00318	CcSEcCtD
Tranylcypromine—Insomnia—Niacin—atherosclerosis	0.000661	0.00317	CcSEcCtD
Tranylcypromine—Abdominal pain—Ezetimibe—atherosclerosis	0.00066	0.00316	CcSEcCtD
Tranylcypromine—Body temperature increased—Ezetimibe—atherosclerosis	0.00066	0.00316	CcSEcCtD
Tranylcypromine—Paraesthesia—Niacin—atherosclerosis	0.000656	0.00314	CcSEcCtD
Tranylcypromine—Feeling abnormal—Simvastatin—atherosclerosis	0.000656	0.00314	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000651	0.00312	CcSEcCtD
Tranylcypromine—Insomnia—Pravastatin—atherosclerosis	0.000651	0.00312	CcSEcCtD
Tranylcypromine—Somnolence—Niacin—atherosclerosis	0.00065	0.00311	CcSEcCtD
Tranylcypromine—Paraesthesia—Pravastatin—atherosclerosis	0.000646	0.00309	CcSEcCtD
Tranylcypromine—Decreased appetite—Niacin—atherosclerosis	0.000635	0.00304	CcSEcCtD
Tranylcypromine—Rash—Rosuvastatin—atherosclerosis	0.000633	0.00303	CcSEcCtD
Tranylcypromine—Dermatitis—Rosuvastatin—atherosclerosis	0.000633	0.00303	CcSEcCtD
Tranylcypromine—Urticaria—Simvastatin—atherosclerosis	0.000632	0.00303	CcSEcCtD
Tranylcypromine—Body temperature increased—Simvastatin—atherosclerosis	0.000629	0.00301	CcSEcCtD
Tranylcypromine—Abdominal pain—Simvastatin—atherosclerosis	0.000629	0.00301	CcSEcCtD
Tranylcypromine—Headache—Rosuvastatin—atherosclerosis	0.000629	0.00301	CcSEcCtD
Tranylcypromine—Decreased appetite—Pravastatin—atherosclerosis	0.000626	0.003	CcSEcCtD
Tranylcypromine—Pain—Niacin—atherosclerosis	0.000625	0.00299	CcSEcCtD
Tranylcypromine—Pain—Pravastatin—atherosclerosis	0.000615	0.00295	CcSEcCtD
Tranylcypromine—Constipation—Pravastatin—atherosclerosis	0.000615	0.00295	CcSEcCtD
Tranylcypromine—Asthenia—Lovastatin—atherosclerosis	0.000611	0.00292	CcSEcCtD
Tranylcypromine—Asthenia—Ezetimibe—atherosclerosis	0.000599	0.00287	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Niacin—atherosclerosis	0.000598	0.00286	CcSEcCtD
Tranylcypromine—Nausea—Rosuvastatin—atherosclerosis	0.000596	0.00286	CcSEcCtD
Tranylcypromine—Feeling abnormal—Pravastatin—atherosclerosis	0.000593	0.00284	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000589	0.00282	CcSEcCtD
Tranylcypromine—Diarrhoea—Lovastatin—atherosclerosis	0.000582	0.00279	CcSEcCtD
Tranylcypromine—Urticaria—Niacin—atherosclerosis	0.000581	0.00278	CcSEcCtD
Tranylcypromine—Body temperature increased—Niacin—atherosclerosis	0.000578	0.00277	CcSEcCtD
Tranylcypromine—Abdominal pain—Niacin—atherosclerosis	0.000578	0.00277	CcSEcCtD
Tranylcypromine—Urticaria—Pravastatin—atherosclerosis	0.000572	0.00274	CcSEcCtD
Tranylcypromine—Asthenia—Simvastatin—atherosclerosis	0.000571	0.00274	CcSEcCtD
Tranylcypromine—Diarrhoea—Ezetimibe—atherosclerosis	0.000571	0.00274	CcSEcCtD
Tranylcypromine—Abdominal pain—Pravastatin—atherosclerosis	0.000569	0.00272	CcSEcCtD
Tranylcypromine—Body temperature increased—Pravastatin—atherosclerosis	0.000569	0.00272	CcSEcCtD
Tranylcypromine—Dizziness—Lovastatin—atherosclerosis	0.000563	0.0027	CcSEcCtD
Tranylcypromine—Dizziness—Ezetimibe—atherosclerosis	0.000552	0.00264	CcSEcCtD
Tranylcypromine—Diarrhoea—Simvastatin—atherosclerosis	0.000545	0.00261	CcSEcCtD
Tranylcypromine—Vomiting—Lovastatin—atherosclerosis	0.000541	0.00259	CcSEcCtD
Tranylcypromine—Rash—Lovastatin—atherosclerosis	0.000537	0.00257	CcSEcCtD
Tranylcypromine—Dermatitis—Lovastatin—atherosclerosis	0.000536	0.00257	CcSEcCtD
Tranylcypromine—Headache—Lovastatin—atherosclerosis	0.000533	0.00255	CcSEcCtD
Tranylcypromine—Vomiting—Ezetimibe—atherosclerosis	0.000531	0.00254	CcSEcCtD
Tranylcypromine—Dizziness—Simvastatin—atherosclerosis	0.000526	0.00252	CcSEcCtD
Tranylcypromine—Rash—Ezetimibe—atherosclerosis	0.000526	0.00252	CcSEcCtD
Tranylcypromine—Dermatitis—Ezetimibe—atherosclerosis	0.000526	0.00252	CcSEcCtD
Tranylcypromine—Asthenia—Niacin—atherosclerosis	0.000524	0.00251	CcSEcCtD
Tranylcypromine—Headache—Ezetimibe—atherosclerosis	0.000523	0.0025	CcSEcCtD
Tranylcypromine—Asthenia—Pravastatin—atherosclerosis	0.000516	0.00247	CcSEcCtD
Tranylcypromine—Vomiting—Simvastatin—atherosclerosis	0.000506	0.00242	CcSEcCtD
Tranylcypromine—Nausea—Lovastatin—atherosclerosis	0.000506	0.00242	CcSEcCtD
Tranylcypromine—Rash—Simvastatin—atherosclerosis	0.000502	0.0024	CcSEcCtD
Tranylcypromine—Dermatitis—Simvastatin—atherosclerosis	0.000501	0.0024	CcSEcCtD
Tranylcypromine—Diarrhoea—Niacin—atherosclerosis	0.0005	0.00239	CcSEcCtD
Tranylcypromine—Headache—Simvastatin—atherosclerosis	0.000499	0.00239	CcSEcCtD
Tranylcypromine—Nausea—Ezetimibe—atherosclerosis	0.000496	0.00237	CcSEcCtD
Tranylcypromine—Diarrhoea—Pravastatin—atherosclerosis	0.000492	0.00236	CcSEcCtD
Tranylcypromine—Dizziness—Niacin—atherosclerosis	0.000483	0.00231	CcSEcCtD
Tranylcypromine—Dizziness—Pravastatin—atherosclerosis	0.000476	0.00228	CcSEcCtD
Tranylcypromine—Nausea—Simvastatin—atherosclerosis	0.000473	0.00226	CcSEcCtD
Tranylcypromine—Vomiting—Niacin—atherosclerosis	0.000465	0.00223	CcSEcCtD
Tranylcypromine—Rash—Niacin—atherosclerosis	0.000461	0.00221	CcSEcCtD
Tranylcypromine—Dermatitis—Niacin—atherosclerosis	0.00046	0.0022	CcSEcCtD
Tranylcypromine—Headache—Niacin—atherosclerosis	0.000458	0.00219	CcSEcCtD
Tranylcypromine—Vomiting—Pravastatin—atherosclerosis	0.000458	0.00219	CcSEcCtD
Tranylcypromine—Rash—Pravastatin—atherosclerosis	0.000454	0.00217	CcSEcCtD
Tranylcypromine—Dermatitis—Pravastatin—atherosclerosis	0.000453	0.00217	CcSEcCtD
Tranylcypromine—Headache—Pravastatin—atherosclerosis	0.000451	0.00216	CcSEcCtD
Tranylcypromine—Nausea—Niacin—atherosclerosis	0.000434	0.00208	CcSEcCtD
Tranylcypromine—Nausea—Pravastatin—atherosclerosis	0.000427	0.00205	CcSEcCtD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.92e-05	0.000247	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.91e-05	0.000246	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—BGN—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.89e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—BGN—atherosclerosis	1.88e-05	0.000242	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.87e-05	0.000242	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.86e-05	0.00024	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AGT—atherosclerosis	1.86e-05	0.00024	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOA5—atherosclerosis	1.86e-05	0.00024	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HMOX1—atherosclerosis	1.85e-05	0.000238	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.83e-05	0.000236	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—APOE—atherosclerosis	1.82e-05	0.000235	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CAV1—atherosclerosis	1.81e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.8e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.8e-05	0.000233	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—APOA1—atherosclerosis	1.8e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.8e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.79e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOB—atherosclerosis	1.77e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.77e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.76e-05	0.000227	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.75e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.75e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.75e-05	0.000225	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.74e-05	0.000225	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.74e-05	0.000224	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.74e-05	0.000224	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.74e-05	0.000224	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOA2—atherosclerosis	1.74e-05	0.000224	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.73e-05	0.000223	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—atherosclerosis	1.72e-05	0.000222	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.71e-05	0.000221	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.71e-05	0.000221	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.7e-05	0.00022	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.7e-05	0.000219	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—LPL—atherosclerosis	1.69e-05	0.000218	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.69e-05	0.000218	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LIPC—atherosclerosis	1.69e-05	0.000218	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.69e-05	0.000218	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOC3—atherosclerosis	1.68e-05	0.000216	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LDLR—atherosclerosis	1.67e-05	0.000215	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LPA—atherosclerosis	1.66e-05	0.000214	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GPX1—atherosclerosis	1.65e-05	0.000213	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CG—atherosclerosis	1.65e-05	0.000212	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CETP—atherosclerosis	1.63e-05	0.00021	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CD36—atherosclerosis	1.61e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—BGN—atherosclerosis	1.6e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.6e-05	0.000206	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPARG—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOA5—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.59e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.56e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.56e-05	0.000201	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—INS—atherosclerosis	1.56e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.56e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.55e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.55e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.54e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.54e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.54e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LIPC—atherosclerosis	1.54e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.53e-05	0.000198	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOC3—atherosclerosis	1.53e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.53e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.53e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—atherosclerosis	1.52e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LDLR—atherosclerosis	1.52e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.52e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.51e-05	0.000195	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CETP—atherosclerosis	1.5e-05	0.000193	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.5e-05	0.000193	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.49e-05	0.000193	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARA—atherosclerosis	1.49e-05	0.000193	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CETP—atherosclerosis	1.49e-05	0.000192	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.48e-05	0.00019	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.47e-05	0.00019	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.46e-05	0.000188	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AGT—atherosclerosis	1.45e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.43e-05	0.000185	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ALB—atherosclerosis	1.43e-05	0.000184	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.42e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOE—atherosclerosis	1.42e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.41e-05	0.000182	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CAV1—atherosclerosis	1.4e-05	0.000181	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOA1—atherosclerosis	1.4e-05	0.000181	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOB—atherosclerosis	1.4e-05	0.00018	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.38e-05	0.000179	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—atherosclerosis	1.37e-05	0.000176	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.36e-05	0.000176	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.36e-05	0.000175	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.35e-05	0.000175	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.34e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—LPL—atherosclerosis	1.34e-05	0.000172	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.33e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.32e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.32e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.32e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.32e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.31e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.31e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GPX1—atherosclerosis	1.3e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.3e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.28e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPA—atherosclerosis	1.28e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CETP—atherosclerosis	1.27e-05	0.000164	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CD36—atherosclerosis	1.27e-05	0.000164	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—atherosclerosis	1.25e-05	0.000161	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—BGN—atherosclerosis	1.24e-05	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARG—atherosclerosis	1.23e-05	0.000159	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.23e-05	0.000158	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.22e-05	0.000157	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.21e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INS—atherosclerosis	1.21e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.2e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.2e-05	0.000154	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.18e-05	0.000153	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARA—atherosclerosis	1.18e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.18e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.15e-05	0.000148	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AGT—atherosclerosis	1.14e-05	0.000147	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.14e-05	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.13e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOE—atherosclerosis	1.12e-05	0.000144	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALB—atherosclerosis	1.11e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CAV1—atherosclerosis	1.11e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOA1—atherosclerosis	1.11e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOB—atherosclerosis	1.08e-05	0.000139	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—atherosclerosis	1.06e-05	0.000137	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.05e-05	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.04e-05	0.000134	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.04e-05	0.000134	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LPL—atherosclerosis	1.03e-05	0.000133	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.03e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.02e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.02e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.02e-05	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.01e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.01e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.01e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LDLR—atherosclerosis	1e-05	0.000129	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—atherosclerosis	1e-05	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOB—atherosclerosis	9.92e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOB—atherosclerosis	9.84e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CETP—atherosclerosis	9.8e-06	0.000126	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CD36—atherosclerosis	9.79e-06	0.000126	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARG—atherosclerosis	9.75e-06	0.000126	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—atherosclerosis	9.71e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.65e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—atherosclerosis	9.57e-06	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INS—atherosclerosis	9.56e-06	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LPL—atherosclerosis	9.48e-06	0.000122	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LPL—atherosclerosis	9.39e-06	0.000121	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.38e-06	0.000121	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.28e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPX1—atherosclerosis	9.25e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPX1—atherosclerosis	9.17e-06	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARA—atherosclerosis	9.1e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CD36—atherosclerosis	9e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CD36—atherosclerosis	8.93e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.86e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AGT—atherosclerosis	8.81e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—atherosclerosis	8.78e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALB—atherosclerosis	8.77e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOE—atherosclerosis	8.64e-06	0.000111	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CAV1—atherosclerosis	8.56e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOA1—atherosclerosis	8.54e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.53e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—atherosclerosis	8.46e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOB—atherosclerosis	8.41e-06	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—atherosclerosis	8.39e-06	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARA—atherosclerosis	8.37e-06	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARA—atherosclerosis	8.3e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.18e-06	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AGT—atherosclerosis	8.11e-06	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AGT—atherosclerosis	8.04e-06	0.000104	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LPL—atherosclerosis	8.03e-06	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOE—atherosclerosis	7.94e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.9e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOE—atherosclerosis	7.87e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CAV1—atherosclerosis	7.87e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOA1—atherosclerosis	7.85e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPX1—atherosclerosis	7.83e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CAV1—atherosclerosis	7.8e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.79e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOA1—atherosclerosis	7.78e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—atherosclerosis	7.67e-06	9.89e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CD36—atherosclerosis	7.63e-06	9.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARG—atherosclerosis	7.52e-06	9.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INS—atherosclerosis	7.38e-06	9.52e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.23e-06	9.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.17e-06	9.25e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	7.11e-06	9.17e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARA—atherosclerosis	7.09e-06	9.15e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARG—atherosclerosis	6.92e-06	8.92e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AGT—atherosclerosis	6.87e-06	8.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARG—atherosclerosis	6.86e-06	8.85e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INS—atherosclerosis	6.79e-06	8.75e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.77e-06	8.74e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALB—atherosclerosis	6.76e-06	8.72e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOE—atherosclerosis	6.73e-06	8.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INS—atherosclerosis	6.73e-06	8.68e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CAV1—atherosclerosis	6.67e-06	8.6e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOA1—atherosclerosis	6.65e-06	8.58e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOB—atherosclerosis	6.49e-06	8.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—atherosclerosis	6.47e-06	8.35e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.31e-06	8.14e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—atherosclerosis	6.28e-06	8.1e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALB—atherosclerosis	6.22e-06	8.02e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LPL—atherosclerosis	6.2e-06	7.99e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALB—atherosclerosis	6.17e-06	7.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.07e-06	7.83e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.04e-06	7.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—atherosclerosis	5.95e-06	7.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.92e-06	7.63e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—atherosclerosis	5.9e-06	7.61e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CD36—atherosclerosis	5.89e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARG—atherosclerosis	5.86e-06	7.56e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INS—atherosclerosis	5.75e-06	7.42e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.58e-06	7.2e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.47e-06	7.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.44e-06	7.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.4e-06	6.96e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AGT—atherosclerosis	5.3e-06	6.84e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALB—atherosclerosis	5.27e-06	6.8e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOE—atherosclerosis	5.19e-06	6.7e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.15e-06	6.64e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.13e-06	6.62e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—atherosclerosis	5.04e-06	6.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—atherosclerosis	4.88e-06	6.29e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.69e-06	6.05e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.61e-06	5.95e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.52e-06	5.84e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INS—atherosclerosis	4.44e-06	5.72e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALB—atherosclerosis	4.07e-06	5.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.89e-06	5.02e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—atherosclerosis	3.85e-06	4.97e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.56e-06	4.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.97e-06	3.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.74e-06	3.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—atherosclerosis	2.71e-06	3.5e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—atherosclerosis	2.32e-06	2.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.79e-06	2.31e-05	CbGpPWpGaD
